erythromycin has been researched along with glucagon-like peptide 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holst, JJ; Kemmeries, G; Meier, JJ; Nauck, MA | 1 |
| Im, MJ; Kim, BJ; Kim, UH; Okamoto, H; Park, KH; Takasawa, S; Yim, CY | 1 |
2 other study(ies) available for erythromycin and glucagon-like peptide 1
| Article | Year |
|---|---|
Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.
Topics: Adult; Blood Glucose; C-Peptide; Cisapride; Domperidone; Eating; Erythromycin; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Humans; Infusions, Intravenous; Insulin; Male; Metoclopramide; Peptide Fragments; Placebos; Protein Precursors; Reference Values | 2005 |
Generation of nicotinic acid adenine dinucleotide phosphate and cyclic ADP-ribose by glucagon-like peptide-1 evokes Ca2+ signal that is essential for insulin secretion in mouse pancreatic islets.
Topics: Acetylcysteine; ADP-ribosyl Cyclase 1; Animals; Calcium; Cyclic ADP-Ribose; Endoplasmic Reticulum; Erythromycin; Glucagon-Like Peptide 1; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Mice, Inbred ICR; Mice, Knockout; NADP; Signal Transduction | 2008 |